Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials

scientific article

Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/GME.0000000000000994
P932PMC publication ID5821577
P698PubMed publication ID29112594

P50authorJoAnn E. MansonQ6204013
Vanessa M BarnabeiQ56462140
Dorothy S LaneQ91756399
Barbara B CochraneQ92707865
Joseph J LarsonQ92889428
Marcia L. StefanickQ109542605
Judith K. OckeneQ113389547
Margery L GassQ114309265
P2093author name stringCharles Mouton
P2860cites workRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trialQ27860743
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trialQ29615226
Self-reported urogenital symptoms in postmenopausal women: Women's Health InitiativeQ30435044
Factors associated with successful discontinuation of hormone therapyQ33571609
Symptom experience after discontinuing use of estrogen plus progestinQ34433581
Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transitionQ34810941
The impact of multimorbidity on sexual function in middle-aged and older women: beyond the single disease perspectiveQ35023884
Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009Q35068765
Sexual activity and satisfaction in healthy community-dwelling older womenQ35634439
Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disordersQ36746505
The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause SocietyQ36793595
Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trialQ37163204
Sexual dysfunction among older adults: prevalence and risk factors from a nationally representative U.S. probability sample of men and women 57-85 years of age.Q37374996
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trialsQ37658616
A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal womenQ39346649
Hormone use and patient concerns after the findings of the Women's Health InitiativeQ39364121
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study GroupQ39513392
Prevalence of genitourinary and other climacteric symptoms in 61-year-old womenQ43330304
Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health InitiativeQ43458097
Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international surveyQ43669097
Ovarian androgen production in postmenopausal womenQ44897806
Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up.Q45157245
Prevalence and impact of vaginal symptoms among postmenopausal womenQ46395492
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal womenQ46468162
Sexual problems and distress in United States women: prevalence and correlates.Q51675955
Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women.Q51689212
Relationship between hypoactive sexual desire disorder and aging.Q51778117
Genitourinary syndrome of menopauseQ56929516
Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause SocietyQ87323247
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)252-264
P577publication date2017-11-06
P1433published inMenopauseQ6817295
P1476titleSexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials
P478volume25

Reverse relations

Q93186260Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Womencites workP2860

Search more.